Canopy Growth (Canopy Growth Stock Quote, Chart, News, Analysts, Financials TSX:WEED) delivered a modest top-line beat in its third quarter, but continued dilution has weighed on the stock, according to Roth Capital Markets analyst Bill Kirk. In a Feb. 10 note, Kirk reiterated his “Buy” rating on Canopy but lowered his price target to C$5.00 […]
Organigram. Buy, Sell or Hold?Moncton, N.B.-headquartered Organigram (Organigram Stock Quote, Chart, News, Analysts, Financials TSX:OGI) reported first-quarter fiscal 2026 results that came in below expectations, but Haywood Securities analyst Neal Gilmer says the company’s strengthened balance sheet and strategic backing support a constructive outlook. In a Feb. 10 note, Gilmer said he recommends buying the shares at current levels, […]